ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 937,90
-0,75%
Dow Jones
38 668,96
0,25%
DAX
18 405,64
-1,10%
Brent Oil
77,755
-0,49%
Bitcoin
70 714,04
2,78%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Avidity Biosciences Inc (RNA)

  7. Avidity Biosciences Inc (RNA) Actualités

RNA Avidity Biosciences Inc

27,64
0,73 (2,71%)
Dernière mise à jour : 19:52:14
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Avidity Biosciences Inc RNA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,73 2,71% 27,64 19:52:14
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
26,75 26,40 27,89 26,91
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/5/202422:05PRNUSAvidity Biosciences to Present Preliminary Data from Phase..
21/5/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
17/5/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202400:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/5/202415:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/5/202415:09EDGAR2Form 8-K - Current report
15/5/202415:00PRNUSAvidity Biosciences Announces Appointment of Simona..
09/5/202422:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09/5/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:07EDGAR2Form 8-K - Current report
09/5/202422:05PRNUSAvidity Biosciences Reports First Quarter 2024 Financial..
08/5/202422:05PRNUSAvidity Biosciences to Participate in Upcoming Investor..
08/5/202412:00PRNUSAvidity Biosciences Receives FDA Breakthrough Therapy..
08/5/202403:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/4/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
27/3/202414:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
21/3/202421:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
08/3/202422:23EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202413:07EDGAR2Form 8-K - Current report
04/3/202413:00PRNUSAvidity Biosciences Announces Positive AOC 1001 Long-term..
01/3/202422:31EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:06EDGAR2Form 8-K - Current report
29/2/202418:00PRNUSAvidity Biosciences Honors Rare Disease Day®
29/2/202413:00PRNUSAvidity Biosciences Announces Oversubscribed $400 Million..
28/2/202423:32EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202422:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202422:05PRNUSAvidity Biosciences Reports Fourth Quarter and Year-End 2023..
27/2/202415:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
21/2/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
20/2/202415:00PRNUSAvidity Biosciences Receives FDA Rare Pediatric Disease..
15/2/202423:00PRNUSAvidity Biosciences to Present New AOC 1001 Long-term..
02/2/202418:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202421:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202421:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202421:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
05/1/202414:36EDGAR2Form 8-K - Current report
05/1/202414:30PRNUSAvidity Biosciences Announces 2024 Corporate Priorities and..
21/12/202322:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
14/12/202322:14EDGAR2Form 8-K - Current report
13/12/202314:30PRNUSAvidity Biosciences Reports Positive Data Demonstrating AOC..
29/11/202312:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
28/11/202313:21DJNBristol Myers Squibb to Take Stake in Avidity Biosciences,..
28/11/202312:31EDGAR2Form 8-K - Current report
28/11/202312:30PRNUSAvidity Biosciences Announces Expansion of Cardiovascular..
21/11/202322:05PRNUSAvidity Biosciences Announces Inducement Grants Under Nasdaq..
21/11/202315:00PRNUSAvidity Biosciences to Participate in Upcoming Investor..
08/11/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dernières Valeurs Consultées

NASDAQ
RNA
Avidity Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés